Trade Summary

6 days ago, Barber Daniel, serving as Pres, CEO at Aquestive Therapeutics, Inc. (AQST), sold 8,257 shares at $4.29 per share, for a total transaction value of $35,413.00. Following this transaction, Barber Daniel now holds 660,574 shares of AQST.

This sale represents a 1.00% decrease in Barber Daniel's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 2:03 PM ET, 3 days after the trade was made.

Aquestive Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.